Finansiella nyckeltal Pfizer Inc.

Aktier

PFE

US7170811035

Farmaceutiska produkter

Marknaden stängd - Nyse Andra börsplatser 22.00.02 2025-12-12			5-dagars förändring	Förändring 1 jan.
25,85 ^USD	+0,19 %		−0,69 %	−2,56 %

12-12	Amerikanska FDA godkänner Innovivas orala antibiotikum mot gonorré	RE
12-12	Pfizer Inc. fastställer utdelning för första kvartalet 2026, som betalas ut den 6 mars 2026	CI

7550f412194dc571563f34.dc8ZsH2CBm8Bs86sE4ftUMOEze7XxTqE4DIQOEc-ouk.NvhY8z7YMlY37KrfW7e5FbmwmJiOmnHlplFqQiFdlI4X-3b_TbpHMFvdnw

Publicerade finansiella data: PFIZER INC.

Årlig

Kvartalsvis

Halvårsvis

YTD

LTM

Skatteperiod: December	2020	2021	2022	2023	2024
Revenues	41,91 md	81,29 md	100 md	58,5 md	63,63 md
Total Revenues	41,91 md	81,29 md	100 md	58,5 md	63,63 md
Cost of Goods Sold, Total	8,57 md	30,66 md	34,1 md	23,99 md	16,42 md
Gross Profit	33,33 md	50,63 md	66,23 md	34,51 md	47,21 md
Selling General & Admin Expenses, Total	10,89 md	9,56 md	12,2 md	13,84 md	14,77 md
R&D Expenses	8,88 md	10,52 md	11,43 md	10,68 md	10,82 md
Amortization of Goodwill and Intangible Assets - (IS)	3,44 md	3,7 md	3,61 md	4,73 md	5,29 md
Other Operating Expenses, Total	23,2 md	23,78 md	27,24 md	29,25 md	30,88 md
Operating Income	10,13 md	26,84 md	39 md	5,26 md	16,33 md
Interest Expense, Total	−1,45 md	−1,29 md	−1,24 md	−2,21 md	−3,09 md
Interest And Investment Income	351 mn	202 mn	565 mn	2,1 md	817 mn
Net Interest Expenses	−1,1 md	−1,09 md	−673 mn	−109 mn	−2,27 md
Income (Loss) On Equity Invest.	298 mn	471 mn	436 mn	505 mn	102 mn
Currency Exchange Gains (Loss)	-	−192 mn	−1,15 md	164 mn	50 mn
Other Non Operating Income (Expenses)	2,29 md	1,88 md	2,62 md	1,28 md	−188 mn
EBT, Excl. Unusual Items	11,62 md	27,92 md	40,22 md	7,09 md	14,02 md
Restructuring Charges	−859 mn	−1,36 md	−2,02 md	−3,33 md	−2,64 md
Merger & Related Restructuring Charges	−528 mn	-	−200 mn	−668 mn	−1,4 md
Gain (Loss) On Sale Of Investments	546 mn	1,34 md	−1,27 md	1,59 md	1,83 md
Gain (Loss) On Sale Of Assets	−237 mn	99 mn	-	222 mn	420 mn
Asset Writedown	−1,69 md	−86 mn	−421 mn	−3,02 md	−3,3 md
In Process R&D Expenses	-	-	−953 mn	−194 mn	−108 mn
Insurance Settlements	-	-	-	-	-
Legal Settlements	−28 mn	−182 mn	−230 mn	−474 mn	−567 mn
Other Unusual Items	−1,32 md	−3,42 md	−394 mn	−157 mn	−239 mn
EBT, Incl. Unusual Items	7,5 md	24,31 md	34,73 md	1,06 md	8,02 md
Income Tax Expense	477 mn	1,85 md	3,33 md	−1,12 md	−28 mn
Earnings From Continuing Operations	7,02 md	22,46 md	31,4 md	2,17 md	8,05 md
Earnings Of Discontinued Operations	2,63 md	−434 mn	6 mn	−15 mn	11 mn
Net Income to Company	9,65 md	22,02 md	31,41 md	2,16 md	8,06 md
Minority Interest	−36 mn	−45 mn	−35 mn	−39 mn	−31 mn
Net Income - (IS)	9,62 md	21,98 md	31,37 md	2,12 md	8,03 md
Preferred Dividend and Other Adjustments	-	-	-	-	-
Net Income to Common Incl Extra Items	9,62 md	21,98 md	31,37 md	2,12 md	8,03 md
Net Income to Common Excl. Extra Items	6,98 md	22,41 md	31,37 md	2,13 md	8,02 md
Per aktie poster
Net EPS - Basic	1,73	3,92	5,59	0,38	1,42
Basic EPS - Continuing Operations	1,26	4	5,59	0,38	1,42
Basic Weighted Average Shares Outstanding	5,56 md	5,6 md	5,61 md	5,64 md	5,66 md
Net EPS - Diluted	1,71	3,85	5,47	0,37	1,41
Diluted EPS - Continuing Operations	1,24	3,93	5,47	0,37	1,41
Diluted Weighted Average Shares Outstanding	5,63 md	5,71 md	5,73 md	5,71 md	5,7 md
Normalized Basic EPS	1,3	3,11	4,48	0,78	1,54
Normalized Diluted EPS	1,28	3,05	4,38	0,77	1,53
Dividend Per Share	1,52	1,56	1,6	1,64	1,68
Payout Ratio	87,77	39,72	28,63	436,38	118,44
American Depositary Receipts Ratio (ADR)	0,25	0,25	0,25	0,25	0,25
Kompletterande punkter
EBITDA	14,89 md	31,95 md	44,02 md	11,52 md	23,32 md
EBITA	13,56 md	30,54 md	42,6 md	9,99 md	21,61 md
EBIT	10,13 md	26,84 md	39 md	5,26 md	16,33 md
EBITDAR	15,66 md	32,84 md	45,24 md	12,8 md	24,5 md
Total Revenues (As Reported)	-	-	-	58,5 md	63,63 md
Effective Tax Rate - (Ratio)	6,36	7,62	9,58	−105,39	−0,35
Current Domestic Taxes	429 mn	3,38 md	2,72 md	1,19 md	485 mn
Current Foreign Taxes	1,52 md	2,77 md	4,37 md	1,14 md	1,59 md
Total Current Taxes	1,95 md	6,14 md	7,09 md	2,33 md	2,07 md
Deferred Domestic Taxes	−1,18 md	−4,34 md	−3,58 md	−2,79 md	−2,2 md
Deferred Foreign Taxes	−292 mn	48 mn	−183 mn	−652 mn	100 mn
Total Deferred Taxes	−1,47 md	−4,29 md	−3,76 md	−3,44 md	−2,1 md
Normalized Net Income	7,23 md	17,4 md	25,11 md	4,39 md	8,73 md
Interest Capitalized	96 mn	108 mn	124 mn	160 mn	182 mn
Non-Cash Pension Expense	−76 mn	−2,14 md	−247 mn	−508 mn	150 mn
Kompletterande driftskostnadsposter
Advertising Expense	1,8 md	2 md	2,8 md	3,7 md	3,3 md
Selling and Marketing Expenses	1,8 md	2 md	2,8 md	3,7 md	3,3 md
Research And Development Expense From Footnotes	9,4 md	13,83 md	11,43 md	10,68 md	11,17 md
Net Rental Expense, Total	773 mn	888 mn	1,22 md	1,28 md	1,18 md
Imputed Operating Lease Interest Expense	202 mn	240 mn	329 mn	424 mn	432 mn
Imputed Operating Lease Depreciation	571 mn	648 mn	889 mn	859 mn	745 mn
Stock-Based Comp., Other (Total)	776 mn	1,2 md	891 mn	545 mn	893 mn
Total Stock-Based Compensation	776 mn	1,2 md	891 mn	545 mn	893 mn

Skatteperiod: December	2020	2021	2022	2023	2024
TILLGÅNGAR
Cash And Equivalents	1,78 md	1,94 md	416 mn	2,85 md	1,04 md
Short Term Investments	10,44 md	29,12 md	22,32 md	9,84 md	19,43 md
Trading Asset Securities, Total	18 mn	4 mn	-	-	-
Total Cash And Short Term Investments	12,24 md	31,07 md	22,73 md	12,69 md	20,48 md
Accounts Receivable, Total	7,93 md	11,48 md	10,95 md	11,18 md	11,46 md
Other Receivables	3,26 md	4,27 md	3,58 md	3,98 md	3,31 md
Total Receivables	11,19 md	15,74 md	14,53 md	15,16 md	14,78 md
Inventory	8,05 md	9,06 md	8,98 md	10,19 md	10,85 md
Other Current Assets, Total	3,59 md	3,82 md	5,02 md	5,3 md	4,25 md
Total Current Assets	35,07 md	59,69 md	51,26 md	43,33 md	50,36 md
Gross Property Plant And Equipment	30,1 md	32,8 md	34,45 md	37,91 md	37,16 md
Accumulated Depreciation	−14,81 md	−15,07 md	−15,17 md	−16,04 md	−16,48 md
Net Property Plant And Equipment	15,29 md	17,72 md	19,28 md	21,86 md	20,68 md
Long-term Investments	20,38 md	21,54 md	14,93 md	15,38 md	2,11 md
Goodwill	49,58 md	49,21 md	51,38 md	67,78 md	68,53 md
Other Intangibles, Total	28,47 md	25,15 md	43,37 md	64,9 md	55,41 md
Deferred Tax Assets Long-Term	900 mn	1,6 md	4,8 md	1,8 md	6,6 md
Other Long-Term Assets, Total	4,54 md	6,57 md	12,2 md	11,44 md	9,71 md
Total Assets	154 md	181 md	197 md	227 md	213 md
Skulder
Accounts Payable, Total	4,31 md	5,58 md	6,81 md	6,71 md	5,63 md
Accrued Expenses, Total	6,51 md	7,67 md	8,32 md	9,22 md	12 md
Short-term Borrowings	701 mn	605 mn	385 mn	8,1 md	3,2 md
Current Portion of Long-Term Debt	2 md	1,64 md	2,57 md	2,27 md	3,78 md
Current Portion of Leases	321 mn	449 mn	620 mn	527 mn	356 mn
Current Income Taxes Payable	1,05 md	1,27 md	1,59 md	2,35 md	2,91 md
Unearned Revenue Current, Total	957 mn	4,02 md	2,52 md	2,7 md	1,51 md
Other Current Liabilities	10,07 md	21,44 md	19,33 md	15,92 md	13,61 md
Total Current Liabilities	25,92 md	42,67 md	42,14 md	47,79 md	43 md
Long-Term Debt	37,13 md	36,2 md	33,2 md	61,81 md	57,8 md
Long-Term Leases	1,11 md	2,51 md	2,6 md	2,63 md	2,29 md
Unearned Revenue Non Current	-	-	-	-	-
Pension & Other Post Retirement Benefits	5,41 md	3,72 md	2,25 md	2,17 md	2,12 md
Deferred Tax Liability Non Current	4,06 md	349 mn	1,02 md	640 mn	2,12 md
Other Non Current Liabilities	17,12 md	18,56 md	20,08 md	22,17 md	17,58 md
Total Liabilities	90,76 md	104 md	101 md	137 md	125 md
Preferred Stock Convertible	-	-	-	-	-
Total Preferred Equity	-	-	-	-	-
Common Stock, Total	470 mn	473 mn	476 mn	478 mn	480 mn
Additional Paid In Capital	88,67 md	90,59 md	91,8 md	92,63 md	93,6 md
Retained Earnings	96,77 md	103 md	126 md	118 md	117 md
Treasury Stock	−111 md	−111 md	−114 md	−114 md	−115 md
Comprehensive Income and Other	−11,69 md	−5,9 md	−8,3 md	−7,96 md	−7,84 md
Total Common Equity	63,24 md	77,2 md	95,66 md	89,01 md	88,2 md
Minority Interest	235 mn	262 mn	256 mn	274 mn	294 mn
Total Equity	63,47 md	77,46 md	95,92 md	89,29 md	88,5 md
Total Liabilities And Equity	154 md	181 md	197 md	227 md	213 md
Kompletterande objekt
ECS Total Shares Outstanding on Filing Date	5,58 md	5,62 md	5,62 md	5,65 md	5,67 md
ECS Total Common Shares Outstanding	5,57 md	5,62 md	5,62 md	5,65 md	5,67 md
Book Value / Share	11,36	13,74	17,03	15,77	15,56
Tangible Book Value	−14,81 md	2,85 md	916 mn	−43,67 md	−35,74 md
Tangible Book Value Per Share	−2,66	0,51	0,16	−7,73	−6,31
Total Debt	41,27 md	41,4 md	39,38 md	75,33 md	67,42 md
Net Debt	29,03 md	10,32 md	16,64 md	62,64 md	46,94 md
Debt Equivalent of Unfunded Proj. Benefit Obligation	4,4 md	1,73 md	1,18 md	561 mn	500 mn
Debt Equivalent Oper. Leases	6,18 md	7,1 md	9,74 md	10,26 md	9,42 md
Minority Interest, Total (Incl. Fin. Div)	235 mn	262 mn	256 mn	274 mn	294 mn
Equity Method Investments, Total	16,86 md	16,47 md	11,03 md	11,64 md	217 mn
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	738 mn	994 mn	859 mn	1,01 md	976 mn
Inventories - Work In Process, Total	4,43 md	4,42 md	5,52 md	5,69 md	6,1 md
Inventories - Finished Goods, Total	2,88 md	3,64 md	2,6 md	3,5 md	3,78 md
Land - (BS)	444 mn	423 mn	368 mn	353 mn	291 mn
Buildings, Total	9,02 md	9 md	8,83 md	9,05 md	9,04 md
Machinery, Total	15,69 md	16,71 md	17,37 md	19,66 md	20,61 md
Full Time Employees	78,5 tn	79 tn	83 tn	88 tn	81 tn
Accumulated Allowance for Doubtful Accounts (Supple)	508 mn	492 mn	449 mn	470 mn	438 mn

Skatteperiod: December	2020	2021	2022	2023	2024
Net Income	9,62 md	21,98 md	31,37 md	2,12 md	8,03 md
Depreciation & Amortization - CF	1,32 md	1,4 md	1,42 md	1,52 md	1,71 md
Amortization of Goodwill and Intangible Assets - (CF)	3,44 md	3,7 md	3,61 md	4,73 md	5,29 md
Depreciation & Amortization, Total	4,76 md	5,1 md	5,03 md	6,26 md	6,99 md
(Gain) Loss From Sale Of Asset	-	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	−6 mn	-	-	-	-
Asset Writedown & Restructuring Costs	2,07 md	363 mn	586 mn	3,44 md	4,26 md
Stock-Based Compensation (CF)	756 mn	1,18 md	872 mn	525 mn	877 mn
Net Cash From Discontinued Operations	3,82 md	−343 mn	-	15 mn	−11 mn
Other Operating Activities, Total	−6,33 md	−8,51 md	−4,14 md	−1,48 md	−4,34 md
Change In Accounts Receivable	−1,25 md	−3,81 md	261 mn	347 mn	−109 mn
Change In Inventories	−736 mn	−1,12 md	592 mn	−1,17 md	−854 mn
Change In Accounts Payable	353 mn	1,24 md	1,19 md	−300 mn	−1,02 md
Change in Other Net Operating Assets	1,36 md	16,5 md	−6,5 md	−1,05 md	−1,08 md
Cash from Operations	14,4 md	32,58 md	29,27 md	8,7 md	12,74 md
Capital Expenditure	−2,25 md	−2,71 md	−3,24 md	−3,91 md	−2,91 md
Cash Acquisitions	-	-	−23 md	−43,43 md	-
Sale (Purchase) of Intangible assets	−539 mn	-	-	-	-
Investment in Marketable and Equity Securities, Total	−1,67 md	−19,52 md	6,68 md	15,24 md	5,56 md
Other Investing Activities, Total	192 mn	−318 mn	3,77 md	−180 mn	0
Cash from Investing	−4,27 md	−22,55 md	−15,78 md	−32,28 md	2,65 md
Short Term Debt Issued, Total	12,35 md	-	3,89 md	7,69 md	8,91 md
Long-Term Debt Issued, Total	5,22 md	997 mn	-	30,83 md	-
Total Debt Issued	17,57 md	997 mn	3,89 md	38,52 md	8,91 md
Short Term Debt Repaid, Total	−26,33 md	−96 mn	−4,11 md	−3 mn	−13,82 md
Long-Term Debt Repaid, Total	−4 md	−2 md	−3,3 md	−2,57 md	−2,25 md
Total Debt Repaid	−30,33 md	−2,1 md	−7,41 md	−2,57 md	−16,07 md
Issuance of Common Stock	425 mn	-	-	-	-
Repurchase of Common Stock	-	-	−2 md	-	-
Common Dividends Paid	−8,44 md	−8,73 md	−8,98 md	−9,25 md	−9,51 md
Common & Preferred Stock Dividends Paid	-	-	-	-	-
Common & Preferred Stock Dividends Paid	−8,44 md	−8,73 md	−8,98 md	−9,25 md	−9,51 md
Other Financing Activities, Total	11,12 md	16 mn	−335 mn	−632 mn	−469 mn
Cash from Financing	−9,65 md	−9,82 md	−14,83 md	26,07 md	−17,14 md
Foreign Exchange Rate Adjustments	−8 mn	−59 mn	−165 mn	−40 mn	−66 mn
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	475 mn	159 mn	−1,52 md	2,45 md	−1,81 md
Kompletterande punkter
Cash Interest Paid	1,64 md	1,47 md	1,44 md	2,22 md	3,23 md
Cash Income Tax Paid (Refund)	3,15 md	7,43 md	7,87 md	3,15 md	3,6 md
Levered Free Cash Flow	10,5 md	30,86 md	24,96 md	1,02 md	12,78 md
Unlevered Free Cash Flow	11,41 md	31,66 md	25,73 md	2,4 md	14,71 md
Change In Net Working Capital	−2,33 md	−11,29 md	1,32 md	3,78 md	474 mn
Net Debt Issued / Repaid	−12,76 md	−1,1 md	−3,52 md	35,94 md	−7,16 md

Skatteperiod: December	2020	2021	2022	2023	2024
Lönsamhet
Return on Assets	3,93	10	12,87	1,55	4,64
Return on Total Capital	5,71	15,01	19,18	2,19	6,37
Return On Equity %	11,06	31,87	36,22	2,35	9,06
Return on Common Equity	11,06	31,92	36,29	2,31	9,05
Marginalanalys
Gross Profit Margin %	79,54	62,28	66,02	58,99	74,19
SG&A Margin	25,99	11,77	12,16	23,65	23,21
EBITDA Margin %	35,52	39,3	43,88	19,69	36,65
EBITA Margin %	32,37	37,58	42,46	17,08	33,97
EBIT Margin %	24,17	33,02	38,87	8,99	25,66
Income From Continuing Operations Margin %	16,75	27,63	31,3	3,71	12,65
Net Income Margin %	22,95	27,04	31,27	3,62	12,62
Net Avail. For Common Margin %	16,67	27,57	31,26	3,65	12,6
Normalized Net Income Margin	17,24	21,41	25,02	7,51	13,72
Levered Free Cash Flow Margin	25,05	37,96	24,87	1,75	20,08
Unlevered Free Cash Flow Margin	27,22	38,95	25,65	4,11	23,12
Tillgångsomslutning
Asset Turnover	0,26	0,48	0,53	0,28	0,29
Fixed Assets Turnover	2,84	4,95	5,42	2,84	2,99
Receivables Turnover (Average Receivables)	5,7	8,38	8,95	5,29	5,53
Inventory Turnover (Average Inventory)	1,13	3,59	3,78	2,5	1,56
Kortfristig likviditet
Current Ratio	1,35	1,4	1,22	0,91	1,17
Quick Ratio	0,9	1,1	0,88	0,58	0,82
Operating Cash Flow to Current Liabilities	0,56	0,76	0,69	0,18	0,3
Days Sales Outstanding (Average Receivables)	64,2	43,54	40,8	69,04	66,23
Days Outstanding Inventory (Average Inventory)	322,59	101,66	96,56	145,84	234,49
Average Days Payable Outstanding	157,02	56,77	66,45	97,92	132,23
Cash Conversion Cycle (Average Days)	229,76	88,42	70,91	116,96	168,49
Långsiktig solvens
Total Debt/Equity	65,02	53,44	41,05	84,37	76,18
Total Debt / Total Capital	39,4	34,83	29,1	45,76	43,24
LT Debt/Equity	60,26	49,97	37,33	72,17	67,9
Long-Term Debt / Total Capital	36,51	32,56	26,46	39,14	38,54
Total Liabilities / Total Assets	58,84	57,32	51,36	60,58	58,53
EBIT / Interest Expense	6,99	20,79	31,5	2,38	5,28
EBITDA / Interest Expense	10,81	25,44	36,54	5,79	7,93
(EBITDA - Capex) / Interest Expense	9,25	23,34	33,93	4,03	6,98
Total Debt / EBITDA	2,64	1,26	0,87	5,89	2,75
Net Debt / EBITDA	1,85	0,31	0,37	4,89	1,92
Total Debt / (EBITDA - Capex)	3,08	1,37	0,94	8,47	3,12
Net Debt / (EBITDA - Capex)	2,17	0,34	0,4	7,04	2,17
Tillväxt jämfört med föregående år
Total Revenues, 1 Yr. Growth %	1,79	95,16	23,43	−41,7	6,84
Gross Profit, 1 Yr. Growth %	0,62	52,11	30,89	−47,9	13,03
EBITDA, 1 Yr. Growth %	5,33	123,2	37,21	−73,84	24,22
EBITA, 1 Yr. Growth %	5,64	135	38,87	−76,55	25,3
EBIT, 1 Yr. Growth %	20,89	178,19	44,54	−86,51	30,45
Earnings From Cont. Operations, 1 Yr. Growth %	−35,39	236,9	39,82	−93,08	270,5
Net Income, 1 Yr. Growth %	−40,91	139,97	42,74	−93,25	279
Normalized Net Income, 1 Yr. Growth %	36,68	168,88	42,98	−82,5	5,57
Diluted EPS Before Extra, 1 Yr. Growth %	−35,06	233,05	39,19	−93,24	281,08
Accounts Receivable, 1 Yr. Growth %	17,1	45,06	−4,59	2,05	−0,89
Inventory, 1 Yr. Growth %	13,84	12,96	−0,86	13,45	6,5
Net Property, Plant and Equip., 1 Yr. Growth %	7,26	17,12	8,77	13,43	−5,41
Total Assets, 1 Yr. Growth %	−7,97	17,67	8,67	14,86	−5,79
Tangible Book Value, 1 Yr. Growth %	−22,1	−119,43	−67,83	−4,87 tn	−18,17
Common Equity, 1 Yr. Growth %	0,18	22,08	23,91	−6,95	−0,91
Cash From Operations, 1 Yr. Growth %	14,42	126,2	−10,17	−70,27	46,48
Capital Expenditures, 1 Yr. Growth %	8,69	21,79	19,37	20,74	−25,54
Levered Free Cash Flow, 1 Yr. Growth %	−24,66	189,11	−19,34	−95,9	129,78
Unlevered Free Cash Flow, 1 Yr. Growth %	−23,55	173,46	−18,95	−90,65	111,91
Dividend Per Share, 1 Yr. Growth %	5,56	2,63	2,56	2,5	2,44
Sammansatt Årlig Tillväxthastighet Över Två År
Total Revenues, 2 Yr. CAGR %	1,32	40,97	55,2	−15,17	−20,7
Gross Profit, 2 Yr. CAGR %	2,14	23,75	41,1	−17,42	−16,11
EBITDA, 2 Yr. CAGR %	5,14	51,84	74,52	−40,09	−27,9
EBITA, 2 Yr. CAGR %	5,92	55,88	80,07	−42,93	−29,47
EBIT, 2 Yr. CAGR %	17,35	81,58	99,57	−55,85	−35,98
Earnings From Cont. Operations, 2 Yr. CAGR %	34,85	44,63	117,04	−68,89	−49,36
Net Income, 2 Yr. CAGR %	−7,15	17,11	85,07	−68,95	−49,4
Normalized Net Income, 2 Yr. CAGR %	23,54	82,62	94,92	−50,06	−41,03
Diluted EPS Before Extra, 2 Yr. CAGR %	39,21	44,32	115,3	−69,32	−49,23
Accounts Receivable, 2 Yr. CAGR %	−0,59	30,19	17,65	−1,32	2,31
Inventory, 2 Yr. CAGR %	3,52	13,21	5,82	6,05	9,92
Net Property, Plant and Equip., 2 Yr. CAGR %	6,89	11,48	12,87	11,08	3,58
Total Assets, 2 Yr. CAGR %	−1,64	4,06	13,08	11,72	4,02
Tangible Book Value, 2 Yr. CAGR %	−23,39	−61,3	−75	291,65	524,6
Common Equity, 2 Yr. CAGR %	−0,12	10,59	22,99	7,38	−3,98
Cash From Operations, 2 Yr. CAGR %	−4,6	60,88	42,55	−48,32	−34,01
Capital Expenditures, 2 Yr. CAGR %	6,54	15,11	20,57	20,05	−5,19
Levered Free Cash Flow, 2 Yr. CAGR %	185,26	47,45	52,29	−81,81	−29,19
Unlevered Free Cash Flow, 2 Yr. CAGR %	132,34	44,45	48,51	−72,48	−25,16
Dividend Per Share, 2 Yr. CAGR %	5,72	4,08	2,6	2,53	2,47
Treårig Sammansatt Årlig Tillväxthastighet
Total Revenues, 3 Yr. CAGR %	−7,26	25,81	34,86	11,99	−7,84
Gross Profit, 3 Yr. CAGR %	−7,21	16,58	26,07	1,23	−2,29
EBITDA, 3 Yr. CAGR %	−10,68	33,37	47,01	−7,29	−10,09
EBITA, 3 Yr. CAGR %	−11,35	36,19	50,21	−8,72	−11,02
EBIT, 3 Yr. CAGR %	−11,7	53,97	68,56	−18,71	−15,41
Earnings From Cont. Operations, 3 Yr. CAGR %	−30,98	79,84	43,01	−31,18	−28,96
Net Income, 3 Yr. CAGR %	−23,3	25,37	25,09	−38,61	−28,51
Normalized Net Income, 3 Yr. CAGR %	−7,51	54,32	68,81	−12,71	−20,87
Diluted EPS Before Extra, 3 Yr. CAGR %	−29,35	83,13	42,59	−32,06	−28,94
Accounts Receivable, 3 Yr. CAGR %	−1,19	12,67	17,38	12,2	−0,05
Inventory, 3 Yr. CAGR %	2,02	6,46	8,31	8,31	6,2
Net Property, Plant and Equip., 3 Yr. CAGR %	3,32	9,81	10,57	13,05	5,29
Total Assets, 3 Yr. CAGR %	−3,53	4,41	5,57	13,67	5,55
Tangible Book Value, 3 Yr. CAGR %	−23,75	−51,68	−63,61	43,9	132,4
Common Equity, 3 Yr. CAGR %	−3,91	6,79	14,86	12,07	4,54
Cash From Operations, 3 Yr. CAGR %	−5,01	27,21	32,48	−15,47	−26,87
Capital Expenditures, 3 Yr. CAGR %	4,81	10,97	16,51	20,63	2,38
Levered Free Cash Flow, 3 Yr. CAGR %	−7,55	188,1	20,7	−54,34	−25,53
Unlevered Free Cash Flow, 3 Yr. CAGR %	−6,78	146,54	19,25	−40,93	−22,62
Dividend Per Share, 3 Yr. CAGR %	5,9	4,68	3,57	2,57	2,5
Sammansatt Årlig Tillväxthastighet Över Fem År
Total Revenues, 5 Yr. CAGR %	−3,02	9	13,81	7,46	9,24
Gross Profit, 5 Yr. CAGR %	−3,33	4,36	9,68	1,55	7,39
EBITDA, 5 Yr. CAGR %	−4,59	10,21	16,08	−3,08	10,97
EBITA, 5 Yr. CAGR %	−4,99	10,97	16,96	−3,74	11,45
EBIT, 5 Yr. CAGR %	−5,99	13,75	21,53	−6,49	14,93
Earnings From Cont. Operations, 5 Yr. CAGR %	0,13	25,44	8,02	−10,86	−5,6
Net Income, 5 Yr. CAGR %	6,68	24,96	8,04	−28,26	−12,91
Normalized Net Income, 5 Yr. CAGR %	−5,07	13,75	22,41	−1,48	10,84
Diluted EPS Before Extra, 5 Yr. CAGR %	2,23	27,42	9,24	−10,38	−5,66
Accounts Receivable, 5 Yr. CAGR %	−0,61	6,89	5,9	6,85	11,1
Inventory, 5 Yr. CAGR %	1,38	5,96	3,46	6,3	8,95
Net Property, Plant and Equip., 5 Yr. CAGR %	2,13	5,88	6,81	10,31	7,72
Total Assets, 5 Yr. CAGR %	−1,62	1,12	2,8	7,28	4,95
Tangible Book Value, 5 Yr. CAGR %	−9,13	−43,06	−51,29	11,59	13,45
Common Equity, 5 Yr. CAGR %	−0,45	5,34	6,06	7,03	6,92
Cash From Operations, 5 Yr. CAGR %	−0,39	15,01	11,74	−11,28	0,25
Capital Expenditures, 5 Yr. CAGR %	10,02	8,26	10,59	14,51	7,29
Levered Free Cash Flow, 5 Yr. CAGR %	−5,32	18,96	13,44	−4,51	−2,08
Unlevered Free Cash Flow, 5 Yr. CAGR %	−4,75	18,25	12,82	2,62	−0,62
Dividend Per Share, 5 Yr. CAGR %	6,3	5,39	4,56	3,82	3,13